Andrew M. Petros

10.3k citations

60 papers · 4.4k indexed · 2 hit papers · h-index 32

Molecular Biology top 2%
Oncology top 5%
Immunology top 5%
Cell Biology top 5%
Computational Theory and Mathematics top 1%

Co-authors: Stephen W. Fesik Edward T. Olejniczak Philip J. Hajduk Robert Meadows David G. Nettesheim Michael E. Greenberg Michael B. Yaffe Linda Hu
Topics: Signaling Pathways in Disease (14 papers)Protein Structure and Dynamics (12 papers)Enzyme Structure and Function (12 papers)
Cited by: Molecular Biology Oncology Computational Theory and Mathematics
Journals: Nature Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United States United Kingdom Canada

In The Last Decade

Andrew M. Petros

59 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structural biology of the Bcl-2 family of proteins

2003 582 citations Andrew M. Petros, Edward T. Olejniczak et al. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research profile →
14-3-3 Proteins and Survival Kinases Cooperate to Inactivate BAD by BH3 Domain Phosphorylation

2000 532 citations Sandeep Robert Datta, Linda Hu et al. Molecular Cell profile →

Peers

Countries citing papers authored by Andrew M. Petros

Since Specialization

Citations

This map shows the geographic impact of Andrew M. Petros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Petros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Petros more than expected).

Fields of papers citing papers by Andrew M. Petros

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew M. Petros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Petros. The network helps show where Andrew M. Petros may publish in the future.

Co-authorship network of co-authors of Andrew M. Petros

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew M. Petros. A scholar is included among the top collaborators of Andrew M. Petros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew M. Petros. Andrew M. Petros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insights into the Conformation and Self-Association of a Concentrated Monoclonal Antibody using Isothermal Chemical Denaturation and Nuclear Magnetic Resonance 2021 ·Journal of Pharmaceutical Sciences ·Jianwen Xu,Andrew T. Namanja,Siew Leong Chan,(unknown),Andrew M. Petros,Chaohong Sun,Czeslaw Radziejewski,(unknown)	2
2	NMR-based fragment screening and lead discovery accelerated by principal component analysis 2019 ·Journal of Biomolecular NMR ·Andrew T. Namanja,Jia Xu,Haihong Wu,Qi Sun,Anup K. Upadhyay,Chaohong Sun,Steven R. Van Doren,Andrew M. Petros	15
3	Fragment-based discovery of potent inhibitors of the anti-apoptotic MCL-1 protein 2014 ·Bioorganic & Medicinal Chemistry Letters ·Andrew M. Petros,(unknown),Danying Song,Kerren K. Swinger,Chang Park,Haichao Zhang,Michael Wendt,Aaron Kunzer,Andrew J. Souers,Chaohong Sun	63
4	Cracking the molecular weight barrier: Fragment screening of an aminotransferase using an NMR-based functional assay 2011 ·Bioorganic & Medicinal Chemistry Letters ·Renaldo Mendoza,Andrew M. Petros,Yaya Liu,Rama Thimmapaya,Carol S. Surowy,(unknown),(unknown),Sanjay C. Panchal,Chaohong Sun	0
5	Fragment-based lead discovery: challenges and opportunities 2011 ·Journal of Computer-Aided Molecular Design ·Chaohong Sun,Andrew M. Petros,Philip J. Hajduk	20
6	Labeled Ligand Displacement: Extending NMR-Based Screening of Protein Targets 2010 ·ACS Medicinal Chemistry Letters ·(unknown),Danying Song,Chaohong Sun,Philip J. Hajduk,Andrew M. Petros	10
7	Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMR 2010 ·Bioorganic & Medicinal Chemistry Letters ·Andrew M. Petros,Jeffrey R. Huth,Thorsten Oost,Cheol‐Min Park,Hong Ding,Xilu Wang,Haichao Zhang,Paul Nimmer,Renaldo Mendoza,Chaohong Sun,J. Mack,Karl A. Walter,Sarah A. Dorwin,(unknown),Uri S. Ladror,Saul H. Rosenberg,Steven W. Elmore,Stephen W. Fesik,Philip J. Hajduk	51
8	Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x _L from NMR and Parallel Synthesis 2005 ·Journal of Medicinal Chemistry ·Andrew M. Petros,Jürgen Dinges,David J. Augeri,(unknown),David A. Betebenner,Mark G. Bures,Steven W. Elmore,Philip J. Hajduk,Mary K. Joseph,(unknown),David G. Nettesheim,Saul H. Rosenberg,Shen Wang,Sheela A. Thomas,Xilu Wang,(unknown),Haichao Zhang,Stephen W. Fesik	229
9	Defining the p53 DNA‐binding domain/Bcl‐x_L‐binding interface using NMR 2004 ·FEBS Letters ·Andrew M. Petros,Angelo Gunasekera,Nan Xu,Edward T. Olejniczak,Stephen W. Fesik	83
10	Structural biology of the Bcl-2 family of proteins 2004 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Andrew M. Petros	6
11	Discovery of novel inhibitors of Bcl-xL using multiple high-throughput screening platforms 2004 ·Analytical Biochemistry ·Jie Qian,Martin J. Voorbach,Jeffrey R. Huth,Michael Coen,Haichao Zhang,Shi‐Chung Ng,Kenneth M. Comess,Andrew M. Petros,Saul H. Rosenberg,Usha Warrior,David J. Burns	56
12	Structural biology of the Bcl-2 family of proteinsbreakdown → 2003 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Andrew M. Petros,Edward T. Olejniczak,Stephen W. Fesik	582
13	Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus 2002 ·Proceedings of the National Academy of Sciences ·Qiulong Huang,Andrew M. Petros,Herbert W. Virgin,Stephen W. Fesik,Edward T. Olejniczak	103
14	14-3-3 Proteins and Survival Kinases Cooperate to Inactivate BAD by BH3 Domain Phosphorylationbreakdown → 2000 ·Molecular Cell ·Sandeep Robert Datta,(unknown),Linda Hu,Andrew M. Petros,Stephen W. Fesik,Michael B. Yaffe,Michael E. Greenberg	532
15	Solution structure of an rRNA methyltransferase (ErmAM) that confers macrolide-lincosamide-streptogramin antibiotic resistance 1997 ·Nature Structural Biology ·Liping Yu,Andrew M. Petros,Arndt Schnuchel,Ping Zhong,Jean M. Severin,Karl A. Walter,Thomas F. Holzman,Stephen W. Fesik	77
16	Solution Structure of the Amino-Terminal Fragment of Urokinase-Type Plasminogen Activator 1994 ·Biochemistry ·(unknown),Andrew M. Petros,Robert Meadows,David G. Nettesheim,Andrew P. Mazar,Edward T. Olejniczak,Robert X. Xu,Terry M. Pederson,Jack Henkin,Stephen W. Fesik	75
17	High-level expression of recombinant human FK-binding protein from a fusion precursor 1992 ·Journal of Protein Chemistry ·Rohinton Edalji,Edward Tam,Steven Pratt,David A. Egan,Jean M. Severin,(unknown),Andrew M. Petros,Stephen W. Fesik,Neal S. Burres,Thomas F. Holzman	19
18	NMR studies of an FK-506 analog, [U-carbon-13]ascomycin, bound to FK-506-binding protein 1992 ·Journal of Medicinal Chemistry ·Andrew M. Petros,Gerd Gemmecker,Placido Neri,Edward T. Olejniczak,David G. Nettesheim,Robert X. Xu,(unknown),(unknown),Stephen W. Fesik	23
19	NMR studies of protein surfaces. The interaction of lysozyme with tri-N-acetylglucosamine 1990 ·Biochemical Pharmacology ·Andrew M. Petros,Kenneth D. Kopple	3
20	Analysis of the aliphatic ¹H‐NMR spectrum of plasminogen kringle 4 1988 ·European Journal of Biochemistry ·Andrew M. Petros,(unknown),László Patthy,Miguel Llinás	13

About Andrew M. Petros

Andrew M. Petros is a scholar working on Molecular Biology, Immunology and Spectroscopy, having authored 60 papers that have together received 4.4k indexed citations. Recurring topics across this work include Signaling Pathways in Disease (14 papers), Protein Structure and Dynamics (12 papers) and Enzyme Structure and Function (12 papers). The work is most often cited by research in Molecular Biology (3.4k citations), Oncology (659 citations) and Computational Theory and Mathematics (356 citations). Andrew M. Petros has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Stephen W. Fesik, Edward T. Olejniczak, Philip J. Hajduk, Robert Meadows, David G. Nettesheim, Michael E. Greenberg, Michael B. Yaffe, Linda Hu, Sandeep Robert Datta and Ho Sup Yoon. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact